MSCI shorts double in a month, cost to borrow triples in a week
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
MSCI stock rose 5% over the past week, yet short sellers kept adding. Short interest has now climbed 59% in a month to 2.58% of the free float, and the cost to borrow tripled in a single week to 0.74%.
Why this matters: The earnings print landed on October 20. The positioning that built ahead of it did not unwind after. Bears who opened into the results are now paying three times more to hold those borrows than they were seven days ago.
What changed after the print
The previous articles on MSCI tracked short interest accelerating into Q3 earnings, reaching 2.58% of float with the cost to borrow cheap at 0.49%. That picture has now shifted on one dimension: the cost to borrow jumped from 0.22% in mid-October to 0.74% as of October 20, a 232% move in a week and 90% above where it was a month ago.
Short interest itself kept climbing too, adding another 0.3% in a single day on October 20. The one-month gain is now 59%, measured in shares short. The underlying borrow pool remains vast, with availability effectively unconstrained, so this is not a squeeze setup. The higher borrow cost reflects increased demand from new short sellers, not a shortage of supply.
Retail attention spikes alongside positioning
Wikipedia views of the MSCI article and ORTEX stock page traffic surged 3.6 standard deviations above their own 90-day average as of October 17. That is an attention signal, not a revenue predictor, but it is notable that retail interest spiked precisely when institutional short sellers were rebuilding positions. The two readings point to heightened awareness around the earnings catalyst from different parts of the market.
What the buyback data shows
MSCI's SEC-reported buyback spend stood at $168.4 million in Q2 2026, up 22% on the same quarter last year. At the same time, buyback spend has fallen for three consecutive quarters. The company is spending more on repurchases year-on-year, but the quarterly trajectory is declining. That is a factual background worth holding when weighing the short thesis: capital returns are active but moderating.
Corroborating context
JP Morgan and Morgan Stanley both trimmed their price targets on October 13 and 14, to $685 and $662 respectively, while maintaining Overweight ratings. The consensus mean target sits at $678, against a close of $591.69. T. Rowe Price added 604,800 shares in the quarter to September 30, the largest institutional move among the top holders. Viking Global Investors holds 1.16 million shares, all added in the June quarter, a new position.
Data summary
- Short interest: 2.58% of free float, up 59% over one month
- Cost to borrow: 0.74%, up 232% over the past week
- Borrow availability: effectively unconstrained
- Retail attention z-score: 3.6 versus 90-day average (as of October 17)
- Buyback spend Q2 2026: $168.4 million, up 22% year-on-year, down for three consecutive quarters
- Stock: up 5% over the past week
- Next earnings: January 26, 2027
Stocks in this article
See the live data behind this article on ORTEX.
Open MSCI on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 11:08
- Data as of
- 21 Oct 2026, 11:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.